Insider Buy/Sell Details for the Shell Companies Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (327)
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
53,000
Price
$28.48
Total Value
$1.51M
Shares Held After
912,312
% of Holdings
5.8%
Redwire Corp (RDW)
AE RED HOLDINGS, LLC — Director
Shares
81,319
Price
$10.01
Total Value
$814.00K
Shares Held After
43,662,407
% of Holdings
0.2%
TriSalus Life Sciences, Inc. (TLSI)
Szela Mary T — Director
Shares
15,944
Price
$3.85
Total Value
$61.38K
Shares Held After
752,987
% of Holdings
2.1%
Redwire Corp (RDW)
AE RED HOLDINGS, LLC — Director
Shares
996,927
Price
$10.10
Total Value
$10.07M
Shares Held After
43,743,726
% of Holdings
2.2%
Oncology Institute, Inc. (TOI)
Chernett Jorey — 10% Owner
Shares
75,000
Price
$3.42
Total Value
$256.50K
Shares Held After
10,251,929
% of Holdings
0.7%
Navitas Semiconductor Corp (NVTS)
GLICKMAN TODD — Sr. V.P., CFO & Treasurer
Shares
98,152
Price
$10.78
Total Value
$1.06M
Shares Held After
735,231
% of Holdings
11.8%
Better Home & Finance Holding Co (BETR)
Smith Chad M. — Pres & COO, Better Mortgage
Shares
2,374
Price
$28.51
Total Value
$67.69K
Shares Held After
18,575
% of Holdings
11.3%
TriSalus Life Sciences, Inc. (TLSI)
Cox Bryan F. — Chief of Research
Shares
579
Price
$4.12
Total Value
$2.39K
Shares Held After
163,415
% of Holdings
0.4%
TriSalus Life Sciences, Inc. (TLSI)
Devlin Jodi — Chief of Clinical Operations
Shares
273
Price
$4.12
Total Value
$1.12K
Shares Held After
97,364
% of Holdings
0.3%
TriSalus Life Sciences, Inc. (TLSI)
Marshak Richard — Chief Commercial Officer
Shares
419
Price
$4.12
Total Value
$1.73K
Shares Held After
110,397
% of Holdings
0.4%
TriSalus Life Sciences, Inc. (TLSI)
Stevens Jennifer — Chief Regulatory Officer
Shares
774
Price
$4.12
Total Value
$3.19K
Shares Held After
124,110
% of Holdings
0.6%
Redwire Corp (RDW)
AE RED HOLDINGS, LLC — Director
Shares
97,066
Price
$10.06
Total Value
$976.48K
Shares Held After
44,740,653
% of Holdings
0.2%
Unusual Machines, Inc. (UMAC)
Rich Sanford — Director
Shares
980
Price
$20.20
Total Value
$19.80K
Shares Held After
205,925
% of Holdings
0.5%
Oncology Institute, Inc. (TOI)
Chernett Jorey — 10% Owner
Shares
60,985
Price
$3.29
Total Value
$200.64K
Shares Held After
10,176,929
% of Holdings
0.6%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
257
Price
$77.94
Total Value
$20.03K
Shares Held After
27,148
% of Holdings
0.9%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
3,065
Price
$77.05
Total Value
$236.16K
Shares Held After
27,405
% of Holdings
10.1%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
2,384
Price
$76.35
Total Value
$182.02K
Shares Held After
30,470
% of Holdings
7.3%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
772
Price
$77.94
Total Value
$60.17K
Shares Held After
58,447
% of Holdings
1.3%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
9,229
Price
$77.05
Total Value
$711.09K
Shares Held After
59,219
% of Holdings
13.5%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
7,178
Price
$76.35
Total Value
$548.03K
Shares Held After
68,448
% of Holdings
9.5%
Better Home & Finance Holding Co (BETR)
Smith Chad M. — Pres & COO, Better Mortgage
Shares
2,567
Price
$29.80
Total Value
$76.50K
Shares Held After
20,949
% of Holdings
10.9%
Unusual Machines, Inc. (UMAC)
Hoff Brian Joseph — Chief Financial Officer
Shares
11,413
Price
$18.59
Total Value
$212.16K
Shares Held After
514,062
% of Holdings
2.2%
Unusual Machines, Inc. (UMAC)
Wright Stacy Rochelle — Chief Revenue Officer
Shares
13,750
Price
$18.57
Total Value
$255.31K
Shares Held After
96,250
% of Holdings
12.5%
Unusual Machines, Inc. (UMAC)
Camden Andrew Ross — President
Shares
9,625
Price
$18.57
Total Value
$178.76K
Shares Held After
356,375
% of Holdings
2.6%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
25,000
Price
$29.55
Total Value
$738.75K
Shares Held After
859,312
% of Holdings
2.9%
Redwire Corp (RDW)
AE RED HOLDINGS, LLC — Director
Shares
11,615
Price
$10.01
Total Value
$116.27K
Shares Held After
44,837,719
% of Holdings
0.0%
Oncology Institute, Inc. (TOI)
Chernett Jorey — 10% Owner
Shares
263,000
Price
$2.92
Total Value
$767.96K
Shares Held After
10,115,944
% of Holdings
2.6%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
501
Price
$6.40
Total Value
$3.21K
Shares Held After
76,940
% of Holdings
0.6%
Oklo Inc. (OKLO)
Cochran Caroline — Director
Shares
72,960
Price
$60.00
Total Value
$4.38M
Shares Held After
751,533
% of Holdings
8.8%
Oklo Inc. (OKLO)
Cochran Caroline — Director
Shares
44,828
Price
$60.00
Total Value
$2.69M
Shares Held After
718,039
% of Holdings
5.9%
Oklo Inc. (OKLO)
DeWitte Jacob — Director
Shares
44,828
Price
$60.00
Total Value
$2.69M
Shares Held After
718,039
% of Holdings
5.9%
Oklo Inc. (OKLO)
DeWitte Jacob — Director
Shares
72,960
Price
$60.00
Total Value
$4.38M
Shares Held After
751,533
% of Holdings
8.8%
Oklo Inc. (OKLO)
Bealmear Richard Craig — Chief Financial Officer
Shares
72,090
Price
$60.00
Total Value
$4.33M
Shares Held After
386,008
% of Holdings
15.7%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
29,494
Price
$34.12
Total Value
$1.01M
Shares Held After
834,312
% of Holdings
3.5%
TriSalus Life Sciences, Inc. (TLSI)
Cox Bryan F. — Chief of Research
Shares
1,467
Price
$4.09
Total Value
$6.00K
Shares Held After
163,994
% of Holdings
0.9%
TriSalus Life Sciences, Inc. (TLSI)
Devlin Jodi — Chief of Clinical Operations
Shares
1,772
Price
$4.09
Total Value
$7.25K
Shares Held After
97,637
% of Holdings
1.8%
TriSalus Life Sciences, Inc. (TLSI)
Marshak Richard — Chief Commercial Officer
Shares
1,589
Price
$4.09
Total Value
$6.50K
Shares Held After
110,816
% of Holdings
1.4%
TriSalus Life Sciences, Inc. (TLSI)
Stevens Jennifer — Chief Regulatory Officer
Shares
1,552
Price
$4.09
Total Value
$6.35K
Shares Held After
124,884
% of Holdings
1.2%
OppFi Inc. (OPFI)
Moore Jocelyn — Director
Shares
8,190
Price
$8.53
Total Value
$69.86K
Shares Held After
39,076
% of Holdings
17.3%
IonQ, Inc. (IONQ)
Raymond John w — Director
Shares
2,800
Price
$33.34
Total Value
$93.35K
Shares Held After
83,963
% of Holdings
3.2%
Hagerty, Inc. (HGTY)
Kuczinski Anthony J — Director
Shares
4,000
Price
$9.50
Total Value
$38.00K
Shares Held After
47,277
% of Holdings
8.5%
SmartRent, Inc. (SMRT)
Bohjalian Thomas N — Director
Shares
150,000
Price
$1.74
Total Value
$260.49K
Shares Held After
500,000
% of Holdings
30.0%
TriSalus Life Sciences, Inc. (TLSI)
Cox Bryan F. — Chief of Research
Shares
1,138
Price
$4.13
Total Value
$4.70K
Shares Held After
165,461
% of Holdings
0.7%
TriSalus Life Sciences, Inc. (TLSI)
Devlin Jodi — Chief of Clinical Operations
Shares
1,162
Price
$4.13
Total Value
$4.80K
Shares Held After
99,409
% of Holdings
1.2%
TriSalus Life Sciences, Inc. (TLSI)
Szela Mary T — Director
Shares
4,358
Price
$4.13
Total Value
$18.00K
Shares Held After
768,931
% of Holdings
0.6%
TriSalus Life Sciences, Inc. (TLSI)
Marshak Richard — Chief Commercial Officer
Shares
1,449
Price
$4.13
Total Value
$5.98K
Shares Held After
112,405
% of Holdings
1.3%
TriSalus Life Sciences, Inc. (TLSI)
Stevens Jennifer — Chief Regulatory Officer
Shares
1,204
Price
$4.13
Total Value
$4.97K
Shares Held After
126,436
% of Holdings
0.9%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
452
Price
$7.26
Total Value
$3.28K
Shares Held After
77,441
% of Holdings
0.6%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
21,598
Price
$39.73
Total Value
$858.09K
Shares Held After
804,818
% of Holdings
2.7%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
19
Price
$7.75
Total Value
$147.25
Shares Held After
77,893
% of Holdings
0.0%
Showing 1–50 of 327 transactions (page 1 of 7)